Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate

NCT00468026 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2007-05-01

No results posted yet for this study

Summary

The purpose of this ex-vivo study is to evaluate the insertion procedure for the ProstaPlant implant in human prostates and the support that it supplies to the prostate.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

ProstaPlant Stent

Sponsors & Collaborators

  • ProstaPlant Urology System Ltd.

    lead INDUSTRY

Principal Investigators

  • Jack Baniel, Prof. · "Rabin" Medical Center - "Belinson" Campus - Urology Department

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00468026 on ClinicalTrials.gov